CAS: 1835-11-6; 1-(4-(Benzyloxy)-3-Methoxyphenyl)Ethanone

该化合物是一种替代的丙酮衍生物,在芳香环上有一个苯氧基和甲氧基功能组,该化合物因其多功能性,特别是作为准备更复杂的分子的中间体,对有机合成和制药研究感兴趣.电子刺激替代体的存在增强了其在电子生殖替代体和其他功能化反应中的效用.其明确界定的结构和稳定性使它适合用于精细化学应用,包括生物活性化合物的开发.该产品的特点通常是高纯度,确保合成工作流程的一贯性能.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

3-Benzyloxy-4-Hydroxyacetophenone 21092-95-5
4-(苄氧基)-3-甲氧基苯甲酰甲基溴化物 3-Methoxy-4-Benzyloxy-α-Bromoacetophenone 1835-12-7
1-(4-(苄氧基)-3-羟基苯基)乙酮 1-[4-(Benzyloxy)-3-Hydroxyphenyl]Ethanone 21092-94-4
4-苄氧基-3-甲氧基苯甲酰乙酸 4-Benzyloxy-3-Methoxybenzoylacetic Acid 78178-58-2
1-(4-苄氧基-3-甲氧基-苯基)-2-(2-甲氧基-苯氧基)-乙酮 1-(4-(Benzyloxy)-3-Methoxyphenyl)-2-(2-Methoxyphenoxy)Ethan-1-One 22317-29-9
Ethyl (4-Benzyloxy-3-Methoxybenzoyl)Acetate 60525-32-8
香草乙酮 1-(3-Methoxy-4-Hydroxyphenyl)Ethanone 498-02-2
3,4-亚甲二氧苯乙酮 1-(Benzo[d][1,3]Dioxol-6-yl)Ethanone 3162-29-6 1-(Benzyloxy)-2-Methoxy-4-Vinylbenzene 55708-65-1 1-(3,4-Dihydroxyphenyl)Ethan-1-One 1197-09-7

合成工艺路线路线简述

    Ethyl (4-Benzyloxy-3-Methoxybenzoyl)Acetate置于硫酸体系中,化学反应生成4-苄氧基-3-甲氧基苯乙酮
    参考文献:Herbert,Richard B.; Jackson,Frederick B.; Nicolson,Ian T.,Journal Of The Chemical Society. Perkin Transactions I,1984,# 4,P. 825-831
    标题:Herbert,Richard B.; Jackson,Frederick B.; Nicolson,Ian T.,Journal Of The Chemical Society. Perkin Transactions I,1984,# 4,P. 825-831

    海关参考信息

    专利信息


    专利号:US-6005103-A
    优先权日:1993-11-19
    标题 :Pyrone derivatives as protease inhibitors and antiviral agents
    发明人:DOMAGALA JOHN MICHAEL; LUNNEY ELIZABETH; PARA KIMBERLY SUZANNE; PRASAD JOSYULA VENKATA NAGENDR; TAIT BRADLEY DEAN
    权利人:WARNER LAMBERT CO
    摘要:The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies for the treatment of bacterial and viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized pyrones and of related structures.

    专利号:US-8524740-B2
    优先权日:2010-07-15
    标 题 :Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
    发明人:KUO SHENG-CHU; LEE KUO-HSIUNG; HUANG LI-JIAU; CHOU LI-CHEN; WU TIAN-SHUNG; WAY TZONG-DER; CHUNG JING-GUNG; YANG JAI-SING; HUANG CHI-HUNG; TSAI MENG-TUNG
    权利人:KUO SHENG-CHU; LEE KUO-HSIUNG; HUANG LI-JIAU; CHOU LI-CHEN; WU TIAN-SHUNG; WAY TZONG-DER; CHUNG JING-GUNG; YANG JAI-SING; HUANG CHI-HUNG; TSAI MENG-TUNG; TAIRX INC
    摘要:A compound of Formula I is disclosed as follows: n n n n n n n n n n n n or a pharmaceutically acceptable salt, prodrug, solvate, or metabolite thereof, wherein n R is hydrogen, P(â•?O)(OH) 2 , P(â•?O)(O(C 1 -C 18 )alkylene(C 6 -C 20 )aryl) 2 , P(â•?O)(OH)(OM), P(â•?O)(OM) 2 , Pâ•?O(O 2 M), S(â•?O)(OH) 2 , S(â•?O)(O(C 1 -C 18 )alkylene(C 6 -C 20 )aryl) 2 , S(â•?O)(OH)(OM), S(â•?O)(OM) 2 ; n M is a monovalent or divalent metal ion, or alkylammonium ion; n W is (C 6 -C 20 )aryl, (C 6 -C 20 )heteroaryl, (C 1 -C 18 )alkyl(C 6 -C 20 )aryl, (C 1 -C 18 )alkyl(C 6 -C 20 )heteroaryl, hydroxy(C 6 -C 20 )aryl, hydroxy(C 6 -C 20 )heteroaryl, (C 1 -C 18 )alkoxy(C 6 -C 20 )aryl, (C 1 -C 18 )alkoxy(C 6 -C 20 )heteroaryl, (C 1 -C 18 )alkylenedioxy(C 6 -C 20 )aryl, (C 1 -C 18 )alkylenedioxy(C 6 -C 20 )heteroaryl, halo(C 6 -C 20 )aryl, halo(C 6 -C 20 )heteroaryl, (C 1 -C 18 )alkylamino(C 6 -C 20 )aryl, (C 1 -C 18 )alkylamino(C 6 -C 20 )heteroaryl, (C 1 -C 18 )cycloalkylamino(C 6 -C 20 )aryl, or (C 1 -C 18 )cycloalkylamino(C 6 -C 20 )heteroaryl, and their OR 8 substutes; n R 5 is (C 1 -C 18 alkoxy, hydrogen, hydroxyl, O—(C 1 -C 18 )alkyl(C 6 -C 20 )aryl, halo or OR 8 , or R 5 and R 6 are (C 1 -C 18 )dioxy provided that R 7 is hydrogen; n R 6 is hydroxyl, O—(C 1 -C 18 )alkyl(C 6 -C 20 )aryl, halo or OR 8 , (C 1 -C 18 )alkoxy, (C 1 -C 18 )alkylamino, or (C 1 -C 18 )cycloalkylamino, or R 6 and R 7 are (C 1 -C 18 )dioxy provided that R 5 is hydrogen; n R 7 is hydrogen, halo or OR 8 , hydroxyl, or O—(C 1 -C 18 )alkyl(C 6 -C 20 )aryl; and n R 8 is P(â•?O)(OH) 2 , P(â•?O)(O(C 1 -C 18 )alkyl(C 6 -C 20 )aryl) 2 , Pâ•?O)(OH)(OM), or P(â•?O)(OM) 2 , Pâ•?O(O 2 M).

    专利号:EP-0729465-B1
    优先权日:1993-11-19
    标 题:Pyrone derivatives as protease inhibitors and antiviral agents
    发明人:DOMAGALA JOHN MICHAEL; LUNNEY ELIZABETH; PARA KIMBERLY SUZANNE; PRASAD JOSYULA VENKATA NAGENDR; TAIT BRADLEY DEAN
    权利人:PARKE DAVIS & CO
    摘要:The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies for the treatment of bacterial and viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized pyrones and of related structures.

    专利号:CA-2805590-C
    优先权日:2010-07-15
    标题 :Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives

    专利号:US-2012015908-A1
    优先权日:2010-07-15
    标 题 :Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives

    专利号:WO-2012009519-A1
    优先权日:2010-07-15
    标题:Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
    安徽德信佳生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jndxj.com
    电话:0531-82375880,0531-82375892👤
    📞 安徽德信佳生物医药有限公司⚠️参考联系方式

    电话: 0531-82375880,0531-82375892
    邮件:sales02@jndxj.com
    网址: http://www.jndxj.com
    地址:安徽省阜阳市太和县经济开发区和谐大道9号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽省阜阳市太和县经济开发区和谐大道9号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#08156
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知